Leadership Team

Peter Weinstein, PhD - Chief Executive Officer

Provides over two decades of legal and business experience working and building small companies in the biotech/pharma/hi tech space around the world; built Genomics Enterprises, the commercial arm of Genomics England that included 12 companies, including many of the largest pharma

Michael Reilly, MBA - Chief Operating Officer

Brings thirty years of international leadership experience in marketing, business development, strategy, and finance at Amgen, Baxter, Sanofi, Sterling Drug, and Eastman Kodak.   Michael was the commercial lead for Amgen's acquisition of Immunex and its drug Enbrel and he led the denosumab (PROLIA, XGEVA) team.